Amphastar Pharmaceuticals Shares Outstanding 2012-2026 | AMPH

Amphastar Pharmaceuticals shares outstanding from 2012 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Amphastar Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2025 48
2024 52
2023 53
2022 52
2021 50
2020 49
2019 50
2018 46
2017 48
2016 48
2015 45
2014 42
2013 39
2012 39
2011 39
Amphastar Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2026-03-31 46
2025-12-31 48
2025-09-30 48
2025-06-30 48
2025-03-31 50
2024-12-31 52
2024-09-30 52
2024-06-30 52
2024-03-31 53
2023-12-31 53
2023-09-30 54
2023-06-30 53
2023-03-31 52
2022-12-31 52
2022-09-30 53
2022-06-30 53
2022-03-31 52
2021-12-31 50
2021-09-30 50
2021-06-30 50
2021-03-31 50
2020-12-31 49
2020-09-30 50
2020-06-30 47
2020-03-31 48
2019-12-31 50
2019-09-30 50
2019-06-30 50
2019-03-31 50
2018-12-31 46
2018-09-30 48
2018-06-30 47
2018-03-31 47
2017-12-31 48
2017-09-30 48
2017-06-30 48
2017-03-31 48
2016-12-31 48
2016-09-30 48
2016-06-30 46
2016-03-31 47
2015-12-31 45
2015-09-30 45
2015-06-30 45
2015-03-31 45
2014-12-31 42
2014-09-30 45
2014-06-30 40
2014-03-31 39
2013-12-31 39
2013-09-30 39
2013-06-30 39
2013-03-31 39
2012-12-31 39
2012-09-30 39
2012-06-30 39
2012-03-31 39
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.924B $0.720B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $35.437B 10.97
BridgeBio Pharma (BBIO) United States $14.460B 0.00
Dr Reddy's Laboratories (RDY) India $11.109B 17.29
Aspen Pharmacare (APNHY) South Africa $3.708B 0.00
Supernus Pharmaceuticals (SUPN) United States $2.918B 22.33
Bausch Health Cos (BHC) Canada $2.086B 1.50
Taysha Gene Therapies (TSHA) United States $1.290B 0.00
Personalis (PSNL) United States $0.630B 0.00
Assembly Biosciences (ASMB) United States $0.451B 0.00
Sol-Gel Technologies (SLGL) Israel $0.210B 0.00
Metagenomi Therapeutics (MGX) United States $0.052B 0.00
Evoke Pharma (EVOK) United States $0.019B 0.00
Teligent (TLGT) United States $0.000B 0.00